BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919 AND Diagnosis
26 results:

  • 1. From the archives of MD Anderson Cancer Center: Sporadic Burkitt lymphoma with a complex karyotype and SOX11 expression.
    Siddiqui SH; Thakral B; Aakash F; Ok CY; Tang Z; Medeiros LJ
    Ann Diagn Pathol; 2023 Oct; 66():152182. PubMed ID: 37543028
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic factors for primary cutaneous anaplastic large-cell lymphoma: a multicentre retrospective study from Japan.
    Miyagaki T; Inoue N; Kamijo H; Boki H; Takahashi-Shishido N; Suga H; Shimauchi T; Kiyohara E; Hirai Y; Yonekura K; Takeuchi K; Sugaya M
    Br J Dermatol; 2023 Oct; 189(5):612-620. PubMed ID: 37539944
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma.
    El Hussein S; Medeiros LJ; Lyapichev KA; Fang H; Jelloul FZ; Fiskus W; Chen J; Wei P; Schlette E; Xu J; Li S; Kanagal-Shamanna R; Yang H; Tang Z; Thakral B; Loghavi S; Jain N; Thompson PA; Ferrajoli A; Wierda WG; Jabbour E; Patel KP; Dabaja BS; Bhalla KN; Khoury JD
    Pathology; 2023 Jun; 55(4):514-524. PubMed ID: 36933995
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted Treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic Leukemia.
    Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
    Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Loss of LEF-1 expression as a diagnostic indicator for extranodal NK/T-cell lymphoma: An immunohistochemical study of 88 cases.
    Qiu C; Du G
    Eur J Haematol; 2022 Nov; 109(5):513-518. PubMed ID: 35871391
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Relevance of Additional Immunohistochemical Markers in the Differential diagnosis of Small B-Cell lymphomas: A Case-Control Study.
    Kıvrak H; Yüksel S; Ateş C; Merter M; Kaygusuz G; Özcan M; Kuzu I
    Turk J Haematol; 2022 Aug; 39(3):178-187. PubMed ID: 34619856
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [A study of lef1 protein expression in diagnosis and differential diagnosis of lymphoblastic lymphoma/acute lymphoblastic leukemia].
    Chen X; Rui WW; Bi K; Wu YJ; Zhang SX; Zhang L; Yu J; Xiu B; Yi XH; Zeng Y
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):207-212. PubMed ID: 33677883
    [No Abstract]    [Full Text] [Related]  

  • 8. Lymphoid enhancer binding factor 1 (lef1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma.
    Lyapichev KA; Sakhdari A; Khoury JD; O'Malley DP; El Hussein S; Yin CC; Patel KP; Thakral B; Young KH; Medeiros LJ; Konoplev S
    Ann Diagn Pathol; 2020 Dec; 49():151636. PubMed ID: 32977233
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Low lef1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia.
    Wang M; Zhang C
    PLoS One; 2020; 15(5):e0232520. PubMed ID: 32401815
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Composite monoclonal B-cell lymphocytosis and MYD88 L265P-positive lymphoplasmacytic lymphoma in a patient with IgM light chain amyloidosis: Case report.
    Oishi N; Inoue T; Odate T; Mochizuki K; Ohashi K; Kirito K; Kondo T
    Pathol Int; 2020 Jul; 70(7):458-462. PubMed ID: 32323419
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Primary Low-Grade B-Cell lymphoma of Skull With Translocation Between Immunoglobulin and Interferon Regulatory Factor 4 Genes.
    Nasim MM; Chalif DJ; Demopoulos AM; Brody J; Lee-Huang R; Spitzer SG; Kolitz JE; Zhang X
    Int J Surg Pathol; 2020 May; 28(3):330-335. PubMed ID: 31631721
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Concurrent cutaneous localization of Langerhans cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma in a patient with a history of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Papoudou-Bai A; Vassou A; Marinos L; Papathanasiou K; Kapsali E; Kanavaros P
    J Cutan Pathol; 2020 Feb; 47(2):161-165. PubMed ID: 31441945
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma.
    Pizzi M; Trentin L; Visentin A; Saraggi D; Martini V; Guzzardo V; Righi S; Frezzato F; Piazza F; Sabattini E; Semenzato G; Rugge M
    Hum Pathol; 2019 Mar; 85():251-259. PubMed ID: 30458196
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
    Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
    Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Diagnostic Utility of Lymphoid Enhancer Binding Factor 1 Immunohistochemistry in Small B-Cell lymphomas.
    Menter T; Trivedi P; Ahmad R; Flora R; Dirnhofer S; Tzankov A; Naresh KN
    Am J Clin Pathol; 2017 Mar; 147(3):292-300. PubMed ID: 28395058
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Sun Y; Wang SA; Sun T
    Cytometry B Clin Cytom; 2018 Jan; 94(1):148-150. PubMed ID: 28109040
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Expression of lef1 in mantle cell lymphoma.
    O'Malley DP; Lee JP; Bellizzi AM
    Ann Diagn Pathol; 2017 Feb; 26():57-59. PubMed ID: 28038713
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Overexpression of lymphoid enhancer-binding factor-1 (lef1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.
    Jia M; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Li SS; Zhang JY; Tang YM
    Int J Lab Hematol; 2015 Oct; 37(5):631-40. PubMed ID: 25955539
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Use of Transcriptional Profiling to Improve Personalized diagnosis and Management of Cutaneous T-cell lymphoma (CTCL).
    Litvinov IV; Netchiporouk E; Cordeiro B; Doré MA; Moreau L; Pehr K; Gilbert M; Zhou Y; Sasseville D; Kupper TS
    Clin Cancer Res; 2015 Jun; 21(12):2820-9. PubMed ID: 25779945
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. lef1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma.
    Menter T; Dirnhofer S; Tzankov A
    J Clin Pathol; 2015 Jun; 68(6):473-8. PubMed ID: 25713417
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.